ASPNAT p.Ala144Val
c.431C>T · rs545710012 · VCV712889
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0814 | likely benign |
|---|---|---|
| REVEL | 0.023 | moderately benign-leaning |
| SaProt | LLR -6.77 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.17 | GERP -3.2, phastCons 0.93 |
| Regional constraint | o/e 0.56 | unconstrained · MANE · 3,077 bp · p 8.6e-12 · regional, not allelic |
| Overall | ||
| CADD | 13.67 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.196% | 511 |
| Remaining individualsnot grpmax-eligible | 0.0146% | 6,867 |
| Admixed American | 0.012% | 8,363 |
| European (non-Finnish) | 0.000682% | 146,694 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ASPNAT
- Protein
- p.Ala144Val
- Coding
- c.431C>T
- MANE Select
- NM_178557
- dbSNP
- rs545710012
- Type
- single nucleotide variant
- Location
- chr4:2061052 (GRCh38)
- Structure
- AlphaFold pLDDT 81.36
- Residue 144
- the n-acetyltransferase domain
Similar variants
- ASPNAT c.541+8C>T Benign ★★ same type
- ASPNAT p.Ala35= Likely benign ★★ same type
- ASPNAT p.Gly263= Likely benign ★★ same type
- ASPNAT p.Pro56= Likely benign ★★ same type
- ASPNAT p.Ala125Thr Uncertain significance ★ ⚠ same type
- ASPNAT p.Ala225Thr Uncertain significance ★ ⚠ same type
- ASPNAT p.Ala22Val Uncertain significance ★ ⚠ same type
- ASPNAT p.Ala255Thr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/aspnat-p-ala144val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown